NCT05516914 2026-04-01A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant TumorsNanjing Leads Biolabs Co.,LtdPhase 1/2 Completed98 enrolled
NCT07112222 2026-01-26A Study of LM-350 in Subjects With Advanced Solid TumoursLaNova Medicines LimitedPhase 1/2 Recruiting80 enrolled